Lee Kyeong-Ryoon相关文献与解析，生知库 | 链接生命科学的每一步

Kim, Dong Gun; Hwang, Kyu-Seok; Ahn, Se Hwan; Kim, Seong Soon; Son, Yuji; Park, Sung Bum; Jung, Won Hoon; Shin, Dae-Seop; Cho, Sung Hee; Choi, Byeong Wook; Kim, Pyeongkeun; Heo, Yerim; Kim, Minhee; Yang, Jung Yoon; Lee, Kyeong-Ryoon; Lee, Hyang-Ae; Kim, Jihun; Kang, Hoon-Chul; Kim, Ki Young; Bae, Myung Ae; Ahn, Jin Hee

癫痫

神经科学

发表日期：2026

文献求助收藏

Pharmacokinetic Landscape and Interaction Potential of SGLT2 Inhibitors: Bridging In Vitro Findings and Clinical Implications

SGLT2抑制剂的药代动力学特征及相互作用潜力：体外研究结果与临床意义的衔接

期刊:Pharmaceutics

影响因子:5.5

doi:10.3390/pharmaceutics17121604

Koo, Nahyun; Lee, Eun Ji; Chang, Ji-Eun; Lee, Kyeong-Ryoon; Chae, Yoon-Jee

SGLT2

发表日期：2025

文献求助收藏

Inhibition of breast cancer resistance protein by flavonols: in vitro, in vivo, and in silico implications of the interactions

黄酮醇对乳腺癌耐药蛋白的抑制作用：体外、体内和计算机模拟研究及其相互作用的意义

期刊:Scientific Reports

影响因子:3.9

doi:10.1038/s41598-025-13908-1

Lee, Kyeong-Ryoon; Kang, Min-Ji; Kim, Min Ju; Im, Yiseul; Jeong, Hyeon-Cheol; Chae, Yoon-Jee

Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management

基于药物相互作用的炎症性肠病管理方法

期刊:Pharmaceutics

影响因子:5.5

doi:10.3390/pharmaceutics16111431

Lee, Kyeong-Ryoon; Gulnaz, Aneela; Chae, Yoon-Jee

Quality by design-based approach for the development of an analytical method for quantifying ponatinib in rat plasma

采用基于质量源于设计的方法开发定量分析大鼠血浆中帕纳替尼的分析方法

期刊:Heliyon

影响因子:3.6

doi:10.1016/j.heliyon.2024.e38637

Koo, Nahyun; Lee, Eun Ji; Kim, Min Ju; Park, Minjung; Lee, Kyeong-Ryoon; Chae, Yoon-Jee

Rat

发表日期：2024

文献求助收藏

Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans

基于生理的药代动力学模型预测钠依赖性葡萄糖转运体2抑制剂依那格列净在人体内的药代动力学

期刊:Pharmaceutics

影响因子:5.5

doi:10.3390/pharmaceutics15030942

Kim, Min-Soo; Song, Yoo-Kyung; Choi, Ji-Soo; Ji, Hye Young; Yang, Eunsuk; Park, Joon Seok; Kim, Hyung Sik; Kim, Min-Joo; Cho, In-Kyung; Chung, Suk-Jae; Chae, Yoon-Jee; Lee, Kyeong-Ryoon

Human

发表日期：2023

文献求助收藏

A Preliminary Study of Pharmacokinetics and Pharmacodynamics of Oral Fingolimod in Dogs

芬戈莫德口服在犬体内的药代动力学和药效学初步研究

期刊:In Vivo

影响因子:1.8

doi:10.21873/invivo.13309

Yun, Taesik; Jeong, Jong-Woo; Koo, Yoonhoi; Chae, Yeon; Lee, Dohee; Kim, Hakhyun; Kim, Soochong; Yang, Mhan-Pyo; Lee, Kyeong-Ryoon; Kang, Byeong-Teck

发表日期：2023

文献求助收藏

Integration of a Physiologically Based Pharmacokinetic and Pharmacodynamic Model for Tegoprazan and Its Metabolite: Application for Predicting Food Effect and Intragastric pH Alterations

基于生理的替戈拉赞及其代谢物的药代动力学和药效学模型的整合：在预测食物效应和胃内pH值变化中的应用

期刊:Pharmaceutics

影响因子:5.5

doi:10.3390/pharmaceutics14061298

Jeong, Hyeon-Cheol; Kim, Min-Gul; Wei, Zhuodu; Lee, Kyeong-Ryoon; Lee, Jaehyeok; Song, Im-Sook; Shin, Kwang-Hee

代谢

发表日期：2022

文献求助收藏

Findings on In Vitro Transporter-Mediated Drug Interactions and Their Follow-Up Actions for Labeling: Analysis of Drugs Approved by US FDA between 2017 and 2021

体外转运体介导的药物相互作用及其后续标签措施的研究结果：对2017年至2021年间美国FDA批准的药物的分析

期刊:Pharmaceutics

影响因子:5.5

doi:10.3390/pharmaceutics14102078

Lee, Kyeong-Ryoon; Chang, Ji-Eun; Yoon, Jongmin; Jin, Hyojeong; Chae, Yoon-Jee

发表日期：2022

文献求助收藏

In Vivo Toxicity and Pharmacokinetics of Polytetrafluoroethylene Microplastics in ICR Mice

聚四氟乙烯微塑料在ICR小鼠体内的毒性和药代动力学

期刊:Polymers

影响因子:4.9

doi:10.3390/polym14112220

Lee, Sijoon; Kang, Kyung-Ku; Sung, Soo-Eun; Choi, Joo-Hee; Sung, Minkyoung; Seong, Keum-Yong; Lee, Jian; Kang, Subin; Yang, Seong Yun; Lee, Sunjong; Lee, Kyeong-Ryoon; Seo, Min-Soo; Kim, KilSoo

毒理研究

发表日期：2022

文献求助收藏

Development of Novel Small-Molecule Targeting SCN1A-Associated Severe Myoclonic Epilepsy of Infancy

开发针对SCN1A相关婴儿严重肌阵挛性癫痫的新型小分子靶向药物

Pharmacokinetic Landscape and Interaction Potential of SGLT2 Inhibitors: Bridging In Vitro Findings and Clinical Implications

SGLT2抑制剂的药代动力学特征及相互作用潜力：体外研究结果与临床意义的衔接

Inhibition of breast cancer resistance protein by flavonols: in vitro, in vivo, and in silico implications of the interactions

黄酮醇对乳腺癌耐药蛋白的抑制作用：体外、体内和计算机模拟研究及其相互作用的意义

Drug Interaction-Informed Approaches to Inflammatory Bowel Disease Management

基于药物相互作用的炎症性肠病管理方法

Quality by design-based approach for the development of an analytical method for quantifying ponatinib in rat plasma

采用基于质量源于设计的方法开发定量分析大鼠血浆中帕纳替尼的分析方法

Physiologically Based Pharmacokinetic Modelling to Predict Pharmacokinetics of Enavogliflozin, a Sodium-Dependent Glucose Transporter 2 Inhibitor, in Humans

基于生理的药代动力学模型预测钠依赖性葡萄糖转运体2抑制剂依那格列净在人体内的药代动力学

A Preliminary Study of Pharmacokinetics and Pharmacodynamics of Oral Fingolimod in Dogs

芬戈莫德口服在犬体内的药代动力学和药效学初步研究

Integration of a Physiologically Based Pharmacokinetic and Pharmacodynamic Model for Tegoprazan and Its Metabolite: Application for Predicting Food Effect and Intragastric pH Alterations

基于生理的替戈拉赞及其代谢物的药代动力学和药效学模型的整合：在预测食物效应和胃内pH值变化中的应用

Findings on In Vitro Transporter-Mediated Drug Interactions and Their Follow-Up Actions for Labeling: Analysis of Drugs Approved by US FDA between 2017 and 2021

体外转运体介导的药物相互作用及其后续标签措施的研究结果：对2017年至2021年间美国FDA批准的药物的分析

In Vivo Toxicity and Pharmacokinetics of Polytetrafluoroethylene Microplastics in ICR Mice

聚四氟乙烯微塑料在ICR小鼠体内的毒性和药代动力学